MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA
Clinical trials for MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial aims to boost fight against aggressive lymphoma
Disease control TerminatedThis study is testing whether adding the drug tazemetostat to standard CHOP chemotherapy works better for people with newly diagnosed T cell lymphoma. About 24 participants will receive the combination treatment, and researchers will measure how well the cancer responds and how l…
Matched conditions: MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Eric Jacobsen, MD • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for Tough-to-Treat blood cancer? trial tests adding drugs to standard chemo
Disease control TerminatedThis study aims to see if adding one of two new drugs (duvelisib or CC-486) to a standard chemotherapy regimen works better for treating newly diagnosed peripheral T-cell lymphoma, a rare and aggressive blood cancer. It will compare the complete remission rates and side effects b…
Matched conditions: MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 31, 2026 12:22 UTC